BAYER HEALTHCARE PHARMACEUTICALS

Bayer Healthcare Pharmaceuticals Inc. specializes in the manufacturing of sterile pharmaceutical preparations and medicinal compounds for federal healthcare and defense systems. The company produces critical therapeutics including radiopharmaceuticals such as Radium Ra-223 dichloride (Xofigo), antimicrobial agents like ciprofloxacin hydrochloride tablets, and contrast media such as iopromide injection, adhering to cGMP standards and stringent FDA regulatory frameworks. Their technical expertise spans aseptic processing, lyophilization, and controlled substance formulation, with demonstrated capability in supplying high-complexity, low-volume specialty drugs required for military and veteran care. The firm’s ability to maintain consistent supply chains for time-sensitive, mission-critical medications underscores its reliability in high-stakes clinical environments. The contractor maintains a sustained relationship with the Department of Veterans Affairs and the Department of Defense, primarily delivering oncology, infectious disease, and diagnostic imaging agents to VA medical centers and military treatment facilities. These engagements reflect a pattern of recurring, mission-aligned procurement for battlefield-ready and chronic care pharmaceuticals, indicating deep integration into federal medical logistics networks. Primary operations center on NAICS 325412 (pharmaceutical preparation manufacturing) and 325411 (medicinal and botanical manufacturing), positioning the firm as a niche supplier of branded and generic injectables and oral solid dosage forms for federal health systems. Their market focus is on specialty pharmaceuticals with complex manufacturing requirements, particularly those requiring radiological handling or cold chain integrity. Based in Whippany, New Jersey, the company operates as a large, privately held manufacturer (Entity Structure 2L) with no active government certifications. Its geographic footprint is centralized but its supply reach extends nationally through federal distribution channels, serving as a trusted source for mission-critical pharmaceuticals within the U.S. government healthcare infrastructure.